Imualfa 1.6mg/1ml Injection 1s

Imualfa 16mg1ml Injection formulated with Thymosin Alpha 1 as its active component is specifically designed to provide support to the immune system This medication is used in the treatment of various clinical conditions such as hepatitis AIDS infections cancer inflammatory disorders cystic fibrosis Lyme disease and others Thymosin Alpha 1 is a synthetic peptide derived from the thymus gland of a calf comprising of 28 amino acid residues Its diverse range of activities includes immune response regulation and inhibition of tumor growth It is important to note that Imualfa 16mg1ml Injection should only be administered under the supervision of a healthcare professional and selfadministration is strongly discouraged Moreover it is not suitable for patients with compromised immune systems such as those who have undergone organ transplantation

Related Faqs

Can I breastfeed while receiving treatment with Tenvir for chronic HBV infection?

No, you should not breastfeed your baby since small amounts of Tenvir pass into breast milk. Further, if your baby does not have HIV or HBV, there is a chance that the baby can get HIV or HBV through breastfeeding.

I vomited after taking Tafnat. What should I do?

If vomiting occurs within 1 hour of taking Tafnat then you should take another tablet. However, if you vomit after more than an hour of taking Tafnat then you need not take another tablet. Consult your doctor if you have vomiting every time you take Tafnat or if the vomiting persists for a longer duration.

I vomited after taking Tafsure. What should I do?

If vomiting occurs within 1 hour of taking Tafsure then you should take another tablet. However, if you vomit after more than an hour of taking Tafsure then you need not take another tablet. Consult your doctor if you have vomiting every time you take Tafsure or if the vomiting persists for a longer duration.

What is drug resistance? Can I develop drug resistance with Hepalo?

Drug resistance is a state where the medicine which was once effective in treating an infection becomes ineffective. This mainly happens due to the ability acquired by the virus or bacteria to get modified inside the body which affects the overall working of the medicine. Hence, the medicine is no longer able to fight against the virus or bacteria. Generally, drug resistance with Hepalo is more likely to happen if you take less dose than what is recommended.

What if HIV infection co-exists with HBV infection? Will this affect treatment with Hivir?

In HBV patients who are diagnosed with HIV, Hivir is not recommended until and unless these patients start taking medicines for HIV management. Starting Hivir in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Hivir.

What if HIV infection co-exists with HBV infection? Will this affect treatment with Lamidac?

In HBV patients who are diagnosed with HIV, Lamidac is not recommended until and unless these patients start taking medicines for HIV management. Starting Lamidac in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Lamidac.